ITMCTR2000003494招募中1 期
Study on the prevention and treatment of atherosclerosis in Shandong Province with integrated traditional Chinese Medicine and Western Medicine-Intervention of Acute Myocardial Infarction with integrated traditional Chinese Medicine and Western Medicine
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 30 至 75（—）
- 性别
- All
入选标准
- •(1) Aged 30-75 years;
- •(2) Patients with STEMI (cTnI peak > 99% URL) in emergency admission who meet the global definition of AMI (version 4) have a rise and fall curve, and have clinical evidence of myocardial ischemia. (see Annex 1 for detailed definition)
- •(3) All patients had received emergency PCI, and TIMI blood flow classification of infarct related artery reached level 3 within 5 days after PCI;
- •(4) Volunteered to participate in this study and informed consent has been signed.
排除标准
- •(1) AMI with uncontrolled severe acute heart failure ;
- •(2) AMI with cardiogenic shock (Killip grade >= I+II), no response to vasopressin;
- •(3) AMI with severe arrhythmia (sustained ventricular tachycardia, ventricular fibrillation), atrioventricular block above grade II, and rapid atrial fibrillation;
- •(4) AMI with mechanical complications (perforation of ventricular septum, rupture of papillary muscle, thrombus in cardiac cavity, rupture of free wall of ventricle);
- •(5) Serious systemic diseases (serious infection, massive hemorrhage caused by anticoagulation and antithrombotic therapy, respiratory failure);
- •(6) History of cerebral hemorrhage and cerebral aneurysm within 3 months;
- •(7) Severe hepatic and renal insufficiency [ALT >= 3 ULN (upper limit of normal), Cr > 134 µ mol / L (2mg / dl) or EGFR < 45ml / min / 1.73m2].
- •(8) Patients with neuropsychiatric diseases;
- •(9) Malignant tumor;
- •(10) Other pathophysiological states with expected survival less than 1 year;
- •(11) Those who are allergic to the ingredients of this study;
- •(12) Pregnant or lactating women;
- •(13) Patients who participated in other clinical studies of traditional Chinese medicine within three months before selection;
- •(14) Other diseases with clinical significance may cause serious risks to patients.
研究者
相似试验
招募中
4 期
A sub-analysis study of the prevention of atherosclerosis by SGLT2 inhibitor (a multicenter, randomized controlled study: PROTECT)Type2 diabetesJPRN-jRCT1071220089ode Koichi482
终止
不适用
Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCBPeripheral Artery DiseaseNCT03676842VentureMed Group Inc.9
招募中
1 期
Clinical study for the treatment of atherosclerotic angiopathy with traditional Chinese MedicineatherosclerosisITMCTR1900002732Hebei Petro China Central Hospital
尚未招募
1 期
Clinical study on prevention and treatment of atherosclerosis in patients with metabolic syndrome with Xiaochaihu decoctioITMCTR2000003261Shanghai Sixth People's Hospital
已完成
不适用
A Clinical Study for arteriosclerosis improvement by percutaneously absorbed lipokinemetabolic syndromeJPRN-UMIN000013138Osaka University Graduate School of Medicine Department of Complementary and Alternative Medicine8